Relapse of postpolycythemia myelofibrosis after allogeneic stem cell transplantation in a polycythemic phase: successful treatment with donor lymphocyte infusion directed by quantitative PCR test for V617F-JAK2 mutation

被引：18

作者：

Benjamini, O. ^{[1
]}

Koren-Michowitz, M. ^{[1
]}

Amariglio, N. ^{[1
]}

Kroger, N. ^{[1
]}

Nagler, A. ^{[1
]}

Shimoni, A. ^{[1
]}

机构：

[1] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel

来源：

LEUKEMIA | 2008年 / 22卷 / 10期

关键词：

D O I：

10.1038/leu.2008.215

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：1961 / 1963

页数：4

共 8 条

[1] Complete remission of idiopathic myelofibrosis following donor lymphocyte infusion after failure of allogeneic transplantation: demonstration of a graft-versus-myelofibrosis effect [J].

Cervantes, F ;

Rovira, M ;

Urbano-Ispizua, A ;

Rozman, M ;

Carreras, E ;

Montserrat, E .

BONE MARROW TRANSPLANTATION, 2000, 26 (06) :697-699

[2] Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders [J].

Jones, AV ;

Kreil, S ;

Zoi, K ;

Waghorn, K ;

Curtis, C ;

Zhang, LY ;

Score, J ;

Seear, R ;

Chase, AJ ;

Grand, FH ;

White, H ;

Zoi, C ;

Loukopoulos, D ;

Terpos, E ;

Vervessou, EC ;

Schultheis, B ;

Emig, M ;

Ernst, T ;

Lengfelder, E ;

Hehlmann, R ;

Hochhaus, A ;

Oscier, D ;

Silver, RT ;

Reiter, A ;

Cross, NCP .

BLOOD, 2005, 106 (06) :2162-2168

[3] A new MALDI-TOF-based assay for monitoring JAK2 V617F mutation level in patients undergoing allogeneic stem cell transplantation (allo SCT) for classic myeloproliferative disorders (MPD) [J].

Koren-Michowitz, Maya ;

Shimoni, Avichai ;

Vivante, Asaf ;

Trakhtenbrot, Luba ;

Rechavi, Gideon ;

Amariglio, Ninette ;

Loewenthal, Ron ;

Nagler, Arnon ;

Cohen, Yoram .

LEUKEMIA RESEARCH, 2008, 32 (03) :421-427

[4] Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis [J].

Kroeger, Nicolaus ;

Thiele, Eirgen ;

Zander, Axel ;

Schwerdtfeger, Rainer ;

Kobbe, Guido ;

Bornhaeuser, Martin ;

Bethge, Wolfgang ;

Schubert, Jorg ;

de Witte, Theo ;

Kvasnicka, Hans Michael .

EXPERIMENTAL HEMATOLOGY, 2007, 35 (11) :1719-1722

[5] Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis [J].

Kroeger, Nicolaus ;

Badbaran, Anita ;

Holler, Ernst ;

Hahn, Joachim ;

Kobbe, Guido ;

Bornhaeuser, Martin ;

Reiter, Andreas ;

Zabelina, Tatjana ;

Zander, Axel R. ;

Fehse, Boris .

BLOOD, 2007, 109 (03) :1316-1321

[6] Allogeneic stem cell transplantation as treatment for myelofibrosis [J].

Papageorgiou, S. G. ;

Castleton, A. ;

Bloor, A. ;

Kottaridis, P. D. .

BONE MARROW TRANSPLANTATION, 2006, 38 (11) :721-727

[7] Non-myeloablative stem cell transplantation (NST): chimerism testing as guidance for immune-therapeutic manipulations [J].

Shimoni, A ;

Nagler, A .

LEUKEMIA, 2001, 15 (12) :1967-1975

[8] REVERSAL OF BONE-MARROW FIBROSIS AND SUBSEQUENT DEVELOPMENT OF POLYCYTHEMIA IN PATIENTS WITH MYELOPROLIFERATIVE DISORDERS [J].

TALARICO, L ;

WOLF, BC ;

KUMAR, A ;

WEINTRAUB, LR .

AMERICAN JOURNAL OF HEMATOLOGY, 1989, 30 (04) :248-253

← 1 →